![]() | Up a level |
Moretti, A.; Fonteyne, L.; Giesert, F.; Hoppmann, P.; Meier, A. B.; Bozoglu, T.; Baehr, A.; Schneider, C. M.; Sinnecker, D.; Klett, K.; Fröhlich, T.; Rahman, F. Abdel; Haufe, T.; Sun, S.; Jurisch, V.; Kessler, B.; Hinkel, R.; Dirschinger, R.; Martens, E.; Jilek, C.; Graf, A.; Krebs, S.; Santamaria, G.; Kurome, M.; Zakhartchenko, V.; Campbell, B.; Voelse, K.; Wolf, A.; Ziegler, T.; Reichert, S.; Lee, S.; Flenkenthaler, F.; Dorn, T.; Jeremias, I.; Blum, H.; Dendorfer, A.; Schnieke, A.; Krause, S.; Walter, M. C.; Klymiuk, N.; Laugwitz, K. L.; Wolf, E.; Wurst, W.; Kupatt, C. (2020): Somatic gene editing ameliorates skeletal and cardiac muscle failure in pig and human models of Duchenne muscular dystrophy. In: Nature Medicine, Vol. 26, No. 2: pp. 207-214
Hinkel, R.; Straub, S.; Batkai, S.; Howe, A.; Klett, K.; Kozlik-Feldmann, R.; Thum, T.; Kupatt, C. (2016): miRNA-132 inhibition prevents fibrosis and hypertrophy in a pig model of percutaneous transverse aortic constriction (pTAC). In: European Heart Journal, Vol. 37: p. 408